Furthermore, in-vitro experiments on U87 human glioblastoma cell lines demonstrated that uptake of ANG1005 was stimulated by acidic, hypoxic, and growth factor-starved conditions commonly associated with an aggressive tumour phenotype, whereas the silencing of LRP1 decreased ANG1005 uptake into cancer cells. This evidence concerns the gene LRP1 and glioblastoma.